The second criterion for establishing a device category, at 419.66(c)(2), provides that CMS determines either of the following: (1) that a device to be included in the category has demonstrated that it will substantially improve the diagnosis or treatment of an illness or injury or improve the functioning of a malformed body part compared to the benefits of a device or devices in a previously established category or other available treatment
Individual Variability: Responses to supplements can vary significantly between individuals due to genetic, lifestyle, and health status differences
For those considering AOD-9604 , realistic expectations and patience are essential
Some patients benefit from weekly or bi-weekly injections to restore low levels, while others may opt for monthly maintenance
Best Pract Res Clin Endocrinol Metab
Similarly to DPI, MitoQ appears to have a greater effect on cells with higher MYCN levels